右奧沙屈

右奧沙屈
臨床資料
ATC碼	未分配;
法律規範狀態
法律規範	Legal;
識別資訊
	IUPAC命名法 (2S)-2-[(4S)-2,2-di(phenyl)-1,3-dioxolan-4-yl]piperidine; ;
CAS號	4741-41-7
PubChem CID	3034023;
ChemSpider	2298576 ;
UNII	JY5N9F45AG;
ChEMBL	ChEMBL1165411 ;
CompTox Dashboard（英語：CompTox Chemicals Dashboard） (EPA)	DTXSID50912321 ;
化學資訊
化學式	C20H23NO2
摩爾質量	309.41 g·mol−1
3D模型（JSmol（英語：JSmol））	交互式圖像;
	SMILES O1C[C@@H](OC1(c2ccccc2)c3ccccc3)[C@H]4NCCCC4;
	InChI InChI=1S/C20H23NO2/c1-3-9-16(10-4-1)20(17-11-5-2-6-12-17)22-15-19(23-20)18-13-7-8-14-21-18/h1-6,9-12,18-19,21H,7-8,13-15H2/t18-,19+/m0/s1 ; Key:HGKAMARNFGKMLC-RBUKOAKNSA-N ;

右奧沙屈（英語：Dexoxadrol 或 Dioxadrol）是一種有機化合物，化學式為C₂₀H₂₃NO₂，屬於解離劑類麻醉藥，具有NMDA受體拮抗劑效果，對動物的影響接近苯環己哌啶。^[1]^[2]

參考文獻

^ Sax M, Wünsch B. Relationships between the structure of dexoxadrol and etoxadrol analogues and their NMDA receptor affinity. Current Topics in Medicinal Chemistry. 2006, 6 (7): 723–32. PMID 16719812. doi:10.2174/156802606776894483.
^ Aepkers M, Wünsch B. Structure-affinity relationship studies of non-competitive NMDA receptor antagonists derived from dexoxadrol and etoxadrol. Bioorganic & Medicinal Chemistry. December 2005, 13 (24): 6836–49. PMID 16169732. doi:10.1016/j.bmc.2005.07.030.